Transmission of attenuated rubella vaccines to the human fetus. A preliminary report.
D000029:Abortion, Legal; D000653:Amniotic Fluid / Q000382:microbiology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D001168:Arthritis / Q000209:etiology; D001769:Blood / Q000382:microbiology; D002584:Cervix Uteri / Q000382:microbiology; D002986:Clinical Trials as Topic; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D005333:Fetus / Q000276:immunology / Q000382:microbiology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008168:Lung / Q000382:microbiology; D008431:Maternal-Fetal Exchange; D009305:Nasopharynx / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D010920:Placenta / Q000382:microbiology; D011247:Pregnancy; D011817:Rabbits; D012409:Rubella / Q000209:etiology / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D014556:Urine / Q000382:microbiology; D014765:Viral Vaccines / Q000009:adverse effects
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines